Senior insider sale
EVP & Chief Commercial Officer at COLLEGIUM PHARMACEUTICAL, INC — senior position signals high conviction
$2.87M
67.58K shares
What this filing means
DREYER SCOTT plans to sell 67.58K shares of COLLEGIUM PHARMACEUTICAL, INC valued at approximately $2.87M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/3/2026ACC: 0001959173-26-001837
Officer· EVP & Chief Commercial Officer
Since Jul 2018
67.58K
Shares to sell
$2.87M
Approx. market value
49.98K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/10/2026
49.98KTotal acquired49.98K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/10/2026 | Restricted Stock Vesting Compensation | 49.98K | — |
| Total | 49.98K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
17.60K
Market value
$847.9K
12/8/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
49.98K
Market value
$2.02M
3/3/2026
Total
Units
67.58K
Value
$2.87M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/8/2025 | 17.60K | $847.9K | — | Completed |
| Planned — Approximate Date | ||||
3/3/2026 | 49.98K | $2.02M | NASDAQ | Planned |
| Total | 67.58K | $2.87M | ||